Literature DB >> 17574582

The effects of erdosteine on lung injury induced by the ischemia-reperfusion of the hind-limbs in rats.

Mehmet Sirmali1, Efkan Uz, Rana Sirmali, Aynur Kilbaş, H Ramazan Yilmaz, Yetkin Ağaçkiran, Irfan Altuntaş, Namik Delibaş.   

Abstract

BACKGROUND: [corrected] The goal of this experimental study was to investigate whether erdosteine has a protective effect against lung injury as a remote organ after hind-limb ischemia-reperfusion (I/R).
MATERIALS AND METHODS: The rats were divided into three groups: control, I/R, and I/R + erdosteine. After the experimental procedure, nitric oxide (NO) levels, myeloperoxidase (MPO), adenosine deaminase (ADA), and the activities of xanthine oxidase (XO) were determined on the lung tissue. The levels of NO and activities of MPO were also measured on the bronchial alveolar lavage (BAL). In addition, the lung tissue was examined by histopathology.
RESULTS: The lung tissue ADA and XO activities were increased in the I/R group compared with the control group (P < 0.05). In the I/R group, the levels of NO were higher than the control group (P < 0.05), whereas the erdosteine treatment did not alter the NO levels (P < 0.05). The MPO activities increased after I/R in the I/R group compared to both control and I/R + erdosteine group (P < 0.05). The activity of MPO increased in the IR group in comparison with the control group in BAL (P < 0.05). The activity of MPO in the I/R + erdosteine group was significantly lower than the I/R group in BAL (P < 0.05). NO levels increased in all I/R groups compared to control group in BAL (P < 0.05). However, treatment of erdosteine significantly decreased NO levels compared to I/R group (P < 0.05). The animals of the I/R group had total destruction of normal alveolar structure with the intense presence of infiltrating neutrophils and mononuclear phagocytes in histopathological examination. The rat lung exhibited mild degrees of destruction in the erdosteine group.
CONCLUSIONS: As a result, erdosteine may be a protective effect for lung injury, decreasing oxidative stress and neutrophil accumulation after hind-limb I/R in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574582     DOI: 10.1016/j.jss.2007.02.027

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine.

Authors:  Ahmet Guven; Turan Tunc; Turgut Topal; Mustafa Kul; Ahmet Korkmaz; Gokhan Gundogdu; Onder Onguru; Haluk Ozturk
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

2.  Proanthocyanidin protects intestine and remote organs against mesenteric ischemia/reperfusion injury.

Authors:  Ali Sizlan; Ahmet Guven; Bulent Uysal; Omer Yanarates; Abdulkadir Atim; Emin Oztas; Ahmet Cosar; Ahmet Korkmaz
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

3.  Prevention of pulmonary complications of pneumoperitoneum in rats.

Authors:  Sami Karapolat; Suat Gezer; Umran Yildirim; Talha Dumlu; Banu Karapolat; Ismet Ozaydin; Mehmet Yasar; Abdulkadir Iskender; Hayati Kandis; Ayhan Saritas
Journal:  J Cardiothorac Surg       Date:  2011-02-08       Impact factor: 1.637

4.  Antioxidant and antiapoptotic effects of erdosteine in a rat model of ovarian ischemia-reperfusion injury.

Authors:  Vedat Ugurel; Ahmet Cagatay Cicek; Mustafa Cemek; Selim Demirtas; A Tuba Kocaman; Turan Karaca
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

5.  Caffeine Mitigates Lung Inflammation Induced by Ischemia-Reperfusion of Lower Limbs in Rats.

Authors:  Wei-Chi Chou; Ming-Chang Kao; Chung-Tai Yue; Pei-Shan Tsai; Chun-Jen Huang
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

6.  Effect of tramadol on lung injury induced by skeletal muscle ischemia-reperfusion: an experimental study.

Authors:  Mohammad Ashrafzadeh Takhtfooladi; Amirali Jahanshahi; Amir Sotoudeh; Gholamreza Jahanshahi; Hamed Ashrafzadeh Takhtfooladi; Kimia Aslani
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.